Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, thank you. A shiny sun and crispy, cool air are enveloping the Pharmalot campus, where our short person is hunched over a laptop once again and our official mascot has settled in for another snooze. As for us, we are in the Pharmalot cafeteria waiting for the coffee kettle to boil so we can indulge in another cup of stimulation. Our choice today is coconut, for those tracking this sort of thing. Meanwhile, here are a few items of interest to help you on your journey. We hope you have a productive day and, of course, stay safe. …

The U.S. will buy 100 million additional shots of the Moderna (MRNA) Covid-19 vaccine — doubling its initial order of the vaccine, which the FDA is expected to authorize later this month, Politico says. The expanded order would ensure continuous vaccine delivery through the end of June 2021, at a total cost of $3.2 billion. Meanwhile, Pfizer (PFE) is still negotiating with the U.S. to provide 100 million more doses of its vaccine in 2021, Reuters notes. In July, the U.S. agreed to pay $1.95 billion for 100 million doses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!